Amicus Therapeutics, Inc. (FOLD) Social Stream
AMICUS THERAPEUTICS INC (FOLD) Price Targets From Analysts
Use the tables below to see what analysts covering AMICUS THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 11 | $29 | $12 | $18.333 | $12.26 | 49.54% |
| 2021-11-15 | 10 | $29 | $12 | $18.444 | $12.26 | 50.44% |
| 2021-11-23 | 9 | $29 | $12 | $17.5 | $12.26 | 42.74% |
| 2022-01-13 | 9 | $29 | $12 | $17.375 | $12.26 | 41.72% |
| 2022-01-17 | 9 | $29 | $15 | $17.875 | $12.26 | 45.8% |
| 2022-01-26 | 9 | $29 | $15 | $17.5 | $12.26 | 42.74% |
| 2022-02-25 | 9 | $29 | $14 | $17 | $12.26 | 38.66% |
| 2022-04-20 | 9 | $20 | $14 | $15.5 | $12.26 | 26.43% |
| 2022-05-10 | 10 | $20 | $11 | $15 | $12.26 | 22.35% |
| 2022-05-12 | 8 | $20 | $11 | $15.125 | $12.26 | 23.37% |
| 2022-08-05 | 7 | $20 | $11 | $15.285 | $12.26 | 24.67% |
| 2022-08-13 | 7 | $20 | $11 | $15.142 | $12.26 | 23.51% |
| 2022-10-19 | 8 | $20 | $11 | $15 | $12.26 | 22.35% |
| 2022-11-07 | 8 | $20 | $11 | $15.125 | $12.26 | 23.37% |
| 2022-11-15 | 8 | $20 | $11 | $15.428 | $12.26 | 25.84% |
| 2023-01-16 | 8 | $20 | $11 | $15.375 | $12.26 | 25.41% |
| 2023-02-08 | 8 | $20 | $11 | $15.875 | $12.26 | 29.49% |
| 2023-03-03 | 9 | $20 | $11 | $16.111 | $12.26 | 31.41% |
| 2023-04-12 | 9 | $20 | $11 | $16.222 | $12.26 | 32.32% |
| 2023-07-11 | 8 | $20 | $11 | $16.111 | $12.26 | 31.41% |
| 2023-08-09 | 8 | $20 | $11 | $16.222 | $12.26 | 32.32% |
| 2023-08-10 | 8 | $20 | $11 | $16.333 | $12.26 | 33.22% |
| 2023-08-16 | 8 | $20 | $11 | $16.444 | $12.26 | 34.13% |
The Trend in the Analyst Price Target
FOLD's average price target has moved down $1.06 over the prior 21 months.
FOLD reports an average of 33.25% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-29 | 8 | 20 | 11 | 15.375 | 12.09 | 27.17% |
| 2023-04-12 | 9 | 20 | 11 | 16.222 | 11.05 | 46.81% |
| 2023-05-01 | 8 | 20 | 11 | 16.111 | 11.90 | 35.39% |
| 2023-05-10 | 8 | 20 | 11 | 16.111 | 11.58 | 39.13% |
| 2023-08-10 | 8 | 20 | 11 | 16.333 | 13.28 | 22.99% |
FOLD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 7 | 0 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
FOLD's average broker recommendation rating improved by 0.35 over the prior 21 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- AMICUS THERAPEUTICS INC's average analyst price target is higher than 586.65% of all US stocks.
- FOLD has a lower variance in analysts' estimates than -2006.32% of all US stocks.
- In the context of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 616.2% of them.
- In the context of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's number of analysts covering the stock is greater than 1838.46% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AMICUS THERAPEUTICS INC are CORT, INVA, and ACAD.
View All Top Stocks by Price Target
What is the outlook for FOLD? Use POWR Ratings for clearer insight into price direction.